Hamburg, Germany, 21 February 2017:
Evotec AG is pleased to announce that LAB282, the £ 13 m (over EUR 15 m) drug discovery partnership with Oxford University, has made its first wave of awards, backing projects targeting cardiovascular diseases and infectious diseases.
Hamburg, Germany, 09 February 2017:
Evotec AG today announced that it resolved on a capital increase from its authorised capital against cash.
Hamburg, Germany, 30 January 2017:
Jefferies' 2017 Celgene Collaborators Summit, New York City, USA
Date: Tuesday, 21 February 2017
Venue: New York City, USA